Blockbuster weight loss drugs have been arguably the biggest health story of the last several years — and there are no signs ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.

After launching a weight-loss drug based on semaglutide, the active ingredient in Wegovy, Hims added 155,000 users in the ...

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

The company shipped some 750 vials of testosterone to customers who had instead ordered ... struggled to meet demand after ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

While GLP-1 medications like Ozempic and Wegovy hold promise for both weight loss and diabetes management, their potential for accidental misuse requires caution.